Remdesivir Injection

Name: Relias Media
Price range: $

June 15, 2020

Under a federal emergency authorization, remdesivir can be used to treat suspected or laboratory-confirmed COVID-19 in children or adults who are hospitalized with severe disease.

Issue Date: June 15, 2020

Table of Contents

Public Health Interventions to Reduce COVID-19 Spread
Masking Our Anxiety
Coronary CT Angiography to Identify Plaque Stabilization
Brief, Targeted Intervention to Stop Smoking
Remdesivir Injection
How Can This Patient Be Stable?
We'd Love to Hear from You!

Financial Disclosure: Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Acadia, AstraZeneca, and Boehringer Ingelheim; and he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, and Novo Nordisk. Peer Reviewer Gerald Roberts, MD; Editor Jonathan Springston; Editor Jason Schneider; Editorial Group Manager Leslie Coplin; and Accreditations Director Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements